Disc Medicine Stock (NASDAQ:IRON)
Previous Close
$89.65
52W Range
$30.82 - $95.95
50D Avg
$66.90
200D Avg
$55.99
Market Cap
$3.05B
Avg Vol (3M)
$429.03K
Beta
2.50
Div Yield
-
IRON Company Profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
IRON Performance
Peer Comparison
| Ticker | Company |
|---|---|
| IDYA | IDEAYA Biosciences, Inc. |
| ADPT | Adaptive Biotechnologies Corporation |
| RXRX | Recursion Pharmaceuticals, Inc. |
| BEAM | Beam Therapeutics Inc. |
| CDTX | Cidara Therapeutics, Inc. |
| BLTE | Belite Bio, Inc |
| IBRX | ImmunityBio, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| ARQT | Arcutis Biotherapeutics, Inc. |